Solventum Corporation (FRA:KB7)

Market Cap	11.01B
Revenue (ttm)	7.14B
Net Income (ttm)	323.57M
Shares Out	n/a
EPS (ttm)	1.86
PE Ratio	34.02
Forward PE	12.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24
Average Volume	93
Open	60.80
Previous Close	62.00
Day's Range	60.80 - 61.40
52-Week Range	51.50 - 80.50
Beta	n/a
RSI	48.36
Earnings Date	Aug 7, 2025

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wr...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KB7

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Financial numbers in USD